Cellectar Biosciences (CLRB) Technical (Analysis) Reports Cellectar Biosciences ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Cellectar Biosciences (CLRB)
Technical Analysis Report for USA stock CLRB Cellectar Biosciences. Dated: 09 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CLRB Cellectar Biosciences then click here. or read Experts views on Cellectar Biosciences or Forecast & share price targets of Cellectar Biosciences
Cellectar Biosciences Opened at 2.50 and Closed at: 2.36, which is -6.36% of previous session's close. It moved within a range of 2.33 and 2.56
The session was a Bearish session with an average volume of 192700, which is 20.34% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Dead cross was found 8 days back on short term averages
A Dead cross was found 2 days back on mid term averages
Support for tomorrow is 2.23 and resistance for tomorrow is 2.46
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 2.27, 2.19 resistance for tomorrow's hourly charts is 2.5, 2.65
10 Day SMA for Cellectar Biosciences (CLRB) is 2.8 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Cellectar Biosciences (CLRB) is 2.96 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Cellectar Biosciences (CLRB) is 2.9 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 3.05 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Cellectar Biosciences is 3.56 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Cellectar Biosciences is at 2.96 and 200 DMA is at 3.56, while 50 DMA and 100 DMA are at 2.9 and 3.05 respectively
Cellectar Biosciences (CLRB) moving average of 20 SMA is at 2.96 and 20 EMA is at 2.87
| Date | Closing Price | 20 SMA | 20 EMA |
| 09 Tue Jun | 2.36 | 2.96 | 2.87 |
| 08 Mon Jun | 2.51 | 2.99 | 2.92 |
| 05 Fri Jun | 2.59 | 3.02 | 2.96 |
| 04 Thu Jun | 2.76 | 3.06 | 3 |
| 03 Wed Jun | 2.59 | 3.1 | 3.02 |
| 02 Tue Jun | 2.76 | 3.14 | 3.06 |
Cellectar Biosciences (CLRB) moving average of 50 SMA is at 2.9 and 50 EMA is at 2.95
| Date | Closing Price | 50 SMA | 50 EMA |
| 09 Tue Jun | 2.36 | 2.9 | 2.95 |
| 08 Mon Jun | 2.51 | 2.91 | 2.97 |
| 05 Fri Jun | 2.59 | 2.91 | 2.99 |
| 04 Thu Jun | 2.76 | 2.92 | 3.01 |
| 03 Wed Jun | 2.59 | 2.92 | 3.02 |
| 02 Tue Jun | 2.76 | 2.93 | 3.04 |
Cellectar Biosciences (CLRB) moving average of 100 SMA is at 3.05 and 100 EMA is at 3.05
| Date | Closing Price | 100 SMA | 100 EMA |
| 09 Tue Jun | 2.36 | 3.05 | 3.05 |
| 08 Mon Jun | 2.51 | 3.06 | 3.06 |
| 05 Fri Jun | 2.59 | 3.08 | 3.07 |
| 04 Thu Jun | 2.76 | 3.09 | 3.08 |
| 03 Wed Jun | 2.59 | 3.09 | 3.09 |
| 02 Tue Jun | 2.76 | 3.1 | 3.1 |
Cellectar Biosciences (CLRB) moving average of 200 SMA is at 3.56 and 200 EMA is at 3.03
| Date | Closing Price | 200 SMA | 200 EMA |
| 09 Tue Jun | 2.36 | 3.56 | 3.03 |
| 08 Mon Jun | 2.51 | 3.57 | 3.04 |
| 05 Fri Jun | 2.59 | 3.58 | 3.05 |
| 04 Thu Jun | 2.76 | 3.59 | 3.05 |
| 03 Wed Jun | 2.59 | 3.6 | 3.05 |
| 02 Tue Jun | 2.76 | 3.61 | 3.05 |
Nu Skin has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Nu Skin, about 2.23% more returns!
Humana Inc has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Humana Inc, about 42.19% more returns!
Glaukos Corporation has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Glaukos Corporation, about 11.83% more returns!
Xbiotech Inc has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Xbiotech Inc, about 13.98% more returns!
Vanda Pharmaceuticals has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Vanda Pharmaceuticals, about 14.35% more returns!
Cellectar Biosciences has performed better than Sensus Healthcare in short term. Holding Cellectar Biosciences could be a better choice for now!
Solid Biosciences has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Solid Biosciences, about 4.28% more returns!
Pulmatrix Inc has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Pulmatrix Inc, about 29.58% more returns!
Cellectar Biosciences has performed better than Petmed Express in short term. Holding Cellectar Biosciences could be a better choice for now!
Minerva Neurosciences has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 3.82% more returns!
Mannkind Corporation has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Mannkind Corporation, about 28.02% more returns!
Moleculin Biotech has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Moleculin Biotech, about 23.03% more returns!
Kura Oncology has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Kura Oncology, about 10.29% more returns!
Kamada has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Kamada, about 5.17% more returns!
Cellectar Biosciences has performed better than Immutep in short term. Holding Cellectar Biosciences could be a better choice for now!
Champions Oncology has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Champions Oncology, about 11.52% more returns!
Aptevo Therapeutics has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Aptevo Therapeutics, about 17.73% more returns!
Altimmune Inc has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Altimmune Inc, about 4.89% more returns!
Achieve Life has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Achieve Life, about 12.68% more returns!
Cellectar Biosciences Technical analysis of indicators
Price action analysis of Cellectar Biosciences (CLRB) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Cellectar Biosciences stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Cellectar Biosciences in short term and the sell signal is strong.
Cellectar Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Cellectar Biosciences in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Cellectar Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.8 and Cellectar Biosciences CLRB stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Cellectar Biosciences CLRB stock. Volume based technical analysis of Cellectar Biosciences CLRB stock is negative.
Cellectar Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CLRB Cellectar Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CLRB Experts View which covers a lot of information including buying and selling signals
CLRB future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cellectar Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Cellectar Biosciences (CLRB) Technical (Analysis) Reports Cellectar Biosciences ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


